Your browser doesn't support javascript.
Insight into Delta variant dominated second wave of COVID-19 in Nepal.
Adhikari, Khagendra; Gautam, Ramesh; Pokharel, Anjana; Dhimal, Meghnath; Uprety, Kedar Nath; Vaidya, Naveen K.
  • Adhikari K; Amrit Campus, Tribhuvan University, Kathmandu, Nepal.
  • Gautam R; Ratna Rajya Laxmi Campus, Tribhuvan University, Kathmandu, Nepal.
  • Pokharel A; Padma Kanya Multiple Campus, Tribhuvan University, Kathmandu, Nepal.
  • Dhimal M; Nepal Health Research Council, Kathmandu, Nepal; Global Institute for Interdisciplinary Studies, Lalitpur, Nepal.
  • Uprety KN; Central Department of Mathematics, Tribhuvan University, Kathmandu, Nepal.
  • Vaidya NK; Department of Mathematics and Statistics, San Diego State University, San Diego, CA, USA; Computational Science Research Center, San Diego State University, San Diego, CA, USA; Viral Information Institute, San Diego State University, San Diego, CA, USA. Electronic address: nvaidya@sdsu.edu.
Epidemics ; 41: 100642, 2022 Oct 06.
Article in English | MEDLINE | ID: covidwho-2061130
ABSTRACT

OBJECTIVE:

To study the spreading nature of Delta variant (B.1.617.2) dominated COVID-19 in Nepal to help the policymakers assess and manage health care facilities and vaccination programs.

METHODS:

Deterministic mathematical models in the form of systems of ordinary differential equations were developed to describe the COVID-19 transmission in the high- and the low-risk regions of Nepal. The models were validated using the multiple data sets containing daily new cases in the whole country, the high-risk region, the low-risk region, and cases needing medical care, ICU, and ventilator.

RESULTS:

We found the reproduction number of Rt=4.2 at the beginning of the second wave, larger than the first wave (∼1.8 estimated previously), indicating that the transmissibility of Delta variant is higher than the wild-type circulated during the first wave. Model predicts that ∼5% of the COVID-19 cases were reported in Nepal, estimating the seroprevalence of ∼63.9% as of July 2021, consistent with the survey conducted by the Government of Nepal. The seroprevalence was expected to reach 94.46% by April 2022, among which ∼46% would have both infection and vaccination. The expected cases from September 2021 to April 2022 is 111,300, among which 11,890 people might need medical care, 3590 need ICU, and 953 need ventilators. The COVID-19 cases and medical care needs could be significantly reduced with proper implementation of vaccination and social distancing.

CONCLUSIONS:

The data-driven mathematical models are useful to assess control programs in resource-limited countries. The appropriate combination of vaccination and social distancing are necessary to keep the pandemic under-control and manage the medical care facilities in Nepal.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study Topics: Vaccines / Variants Language: English Journal: Epidemics Year: 2022 Document Type: Article Affiliation country: J.epidem.2022.100642

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study Topics: Vaccines / Variants Language: English Journal: Epidemics Year: 2022 Document Type: Article Affiliation country: J.epidem.2022.100642